About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,466 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,466 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 22,466 trials

Active not recruitingContinued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are ClosingThis Master Protocol for Avelumab Continuation Sub-Studies is to provide continued treatment access, safety follow-up, and when applicable, overall survival follow-up for eligible…NCT05059522·Fayetteville, Arkansas and 70 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

CompletedThe MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)The MOOD study will evaluate the safety and efficacy of a noninvasive, self-administered external Combined Occipital and Trigeminal Neurostimulation (eCOT-NS) treatment for Major…NCT04279522·La Jolla, California and 12 others

CompletedEfficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected AdultsThis study will evaluate the efficacy, safety, and tolerability of sofosbuvir (SOF; GS-7977) plus ribavirin (RBV) in adults with chronic genotypes 1, 2, and 3 HCV infection who…NCT01667731·Birmingham, Alabama and 26 others

CompletedPRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinThis clinical research study is to investigate the prevention of relapse in patients with diffuse large B cell lymphoma (DLBCL) using enzastaurin daily.NCT00332202·Anchorage, Alaska and 152 others

Active not recruitingFirst-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsThis is the first clinical trial of IDRX-42.NCT05489237·Miami, Florida and 30 others

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

RecruitingEvaluating a Culinary Curriculum Program for Residents of Medication Assisted Therapy (MAT) Recovery HousesThe purpose of the study is to assess a culinary curriculum in persons with substance use disorder who are receiving medication assisted therapy and who are in recovery residences…NCT07251205·Houston, Texas

CompletedLenalidomide for Patients With Myelofibrosis (MF)The goal of this clinical research study is to learn if lenalidomide in combination with prednisone can help to control myelofibrosis.NCT00352794·Houston, Texas

CompletedPhase III Study of AZD7442 for Treatment of COVID-19 in Outpatient AdultsThis Phase III study will assess whether AZD7442 (a combination of 2 mAbs) can safely treat outpatient adults with COVID-19 and prevent either severe COVID-19 or death.NCT04723394·Jasper, Alabama and 102 others

CompletedA Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaThe primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.NCT03142451·Tucson, Arizona and 53 others

UnknownMulti-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal DisorderThis study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by…NCT04948151·Mobile, Alabama and 50 others

CompletedStudy of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHDA Phase IIa single arm open-label study to investigate the safety, tolerability, and PK of F-652 in combination with systemic corticosteroids in subjects who have undergone…NCT02406651·Duarte, California and 2 others

CompletedIbrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)This is a multicenter, 2-cohort Phase 2 study assessing both minimal residual disease (MRD)-guided discontinuation and fixed duration therapy with the combination of ibrutinib +…NCT02910583·Duarte, California and 45 others

CompletedA Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus InfectionDose cohorts may be dosed with one of up to 4 possible total weekly doses (0.3 mg, 1 mg, 2 mg, 4 mg).NCT01590654·Phoenix, Arizona and 19 others

TerminatedExtension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 StudyPrimary Objective To monitor and evaluate the long-term safety and tolerability of EDS-EP in AT patients.NCT03563053·Los Angeles, California and 16 others

CompletedFilibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 SubjectsThe primary objective for this study is to determine if the addition of filibuvir to a standard regimen of peginterferon/ribavirin (pegIFN/RBV) significantly increases the…NCT00987337·Anaheim, California and 76 others

CompletedMaximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisThis is an open-label, multicenter study to evaluate the systemic exposure and safety of topical tapinarof cream, 1% under conditions of maximal use in pediatric subjects with…NCT05186805·Thousand Oaks, California and 9 others

CompletedRadiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00304031·Fairbanks, Alaska and 350 others

CompletedA Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)This study will evaluate the efficacy, safety and pharmacodynamics of elexacaftor (ELX, VX-445) in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects…NCT04058353·Birmingham, Alabama and 92 others

CompletedEfficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain DisordersThe purpose of this study is to: 1.NCT03100487·Houston, Texas

PreviousPage 8 of 1124Next

in Houston

Heart Diseasein Houston